Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Antibody Responses to Two Recombinant Treponemal Antigens (rp17 and TmpA) before and after Azithromycin Treatment for Yaws in Ghana and Papua New Guinea.
Parameswaran, N; Mitjà, O; BOTTOMLEY, C; Kwakye, C; Houinei, W; Pillay, A; Danavall, D; Chi, K-H; Ballard, RC; Solomon, AW; Chen, CY; Bieb, SV; Adu-Sarkodie, Y; MABEY, DC W; Asiedu, K; MARKS, M; Martin, DL;
2021
Journal of clinical microbiology, (2021).59 5 10.1128/JCM.02509-20.
Who should be prioritized for COVID-19 vaccination in China? A descriptive study.
Yang, J; Zheng, W; Shi, H; Yan, X; Dong, K; You, Q; Zhong, G; Gong, H; Chen, Z; JIT, M; Viboud, C; Ajelli, M; Yu, H;
2021
BMC medicine, (2021).19 1 10.1186/s12916-021-01923-8.
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.
ISHOLA, D; MANNO, D; AFOLABI, MO; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; BAIDEN, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; Gallagher, KE; Gaddah, A; ... EBL3001 study group,
2021
Lancet Infectious Diseases, (2021).22 1 10.1016/S1473-3099(21)00125-0.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
AFOLABI, MO; ISHOLA, D; MANNO, D; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; Baiden, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; GALLAGHER, KE; Gaddah, A; ... EBL3001 study group,
2021
Lancet Infectious Diseases, (2021).22 1 10.1016/S1473-3099(21)00128-6.
Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis.
PREM, K; Choi, YH; Bénard, É; Burger, E; Hadley, L; Laprise, J-F; Regan, MC; Drolet, M; Sy, S; Abbas, K; Portnoy, A; Kim, J; Brisson, M; JIT, M;
2021
medRxiv (2021). 10.1101/2021.02.08.21251186.
Methods for Social Media Monitoring Related to Vaccination: Systematic Scoping Review.
Karafillakis, E; Martin, S; Simas, C; Olsson, K; Takacs, J; DADA, S; LARSON, HJ;
2021
JMIR public health and surveillance, (2021).7 2 10.2196/17149.
Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA.
Loomba, S; DE FIGUEIREDO, A; PIATEK, SJ; De Graaf, K; LARSON, HJ;
2021
Nature human behaviour, (2021).5 3 10.1038/s41562-021-01056-1.
The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya.
MBURU, CN; OJAL, J; Chebet, R; Akech, D; Karia, B; Tuju, J; Sigilai, A; ABBAS, K; JIT, M; FUNK, S; Smits, G; Van Gageldonk, PG M; Van der Klis, FR M; Tabu, C; Nokes, DJ; LSHTM CMMID COVID-19 Working Group,; SCOTT, J; FLASCHE, S; ADETIFA, I;
2021
BMC medicine, (2021).19 1 10.1186/s12916-021-01906-9.
Antibody Responses to Crude Gametocyte Extract Predict Plasmodium falciparum Gametocyte Carriage in Kenya.
Omondi, BR; Muthui, MK; Muasya, WI; Orindi, B; Mwakubambanya, RS; Bousema, T; DRAKELEY, C; Marsh, K; Bejon, P; Kapulu, MC;
2021
Frontiers in immunology, (2021).11, 10.3389/fimmu.2020.609474.
Assessing COVID-19 Vaccine Hesitancy, Confidence, and Public Engagement: A Global Social Listening Study (Preprint).
Hou, Z; Tong, Y; Du, F; Lu, L; Zhao, S; Yu, K; Piatek, SJ; LARSON, HJ; LIN, L;
2021
JMIR Publications Inc. (2021). 10.2196/preprints.27632.